RMD
Medical Instruments & Supplies · Healthcare
Analyst
KeyBanc Capital Markets
Equibles does not estimate personal net worth.
Brett Fishbin is recorded as Analyst at KeyBanc Capital Markets. Brett Fishbin has spoken on 5 earnings calls across 5 companies, most recently for Resmed Inc on August 6, 2026. Those appearances were for Resmed Inc (RMD), Lemaitre Vascular Inc (LMAT), Alcon Inc (ALC), Cooper Companies, Inc. (COO) and Integer Holdings Corp (ITGR). The companies whose calls Brett Fishbin spoke on are classified in the Healthcare sector.
“I guess I'll just continue on the astral line of questioning while you're kind of on the topic. How does the 130 basis point expected headwind for the year relate to the EPS guidance?”
“You know, the geographical performance versus our model, at least, looked pretty good in Europe and in Asia. And America's was a little bit softer than expected.”
“So you took the tariff estimate down by $25 million within the guide and mentioned that the plan would be to reinvest within the business. So just curious where you saw incremental need for greater investment activity rather than, you know, potentially letting that drop down to earnings.”
“Hopefully, there's not too much feedback. Just wanted to circle back on the 1Q operating margin performance, which I think you noted in the press release was better than expected and obviously is a top priority this year.”
“Just wanted to start off on the guidance a little bit on some of the segment moving pieces. is on cardio and vascular, you know, the segment was really growing in the low double-digit range from 2021 to 2023.”
KeyBanc Capital Markets
Analyst
Source not stated
RMD
Medical Instruments & Supplies · Healthcare
Medical Instruments & Supplies · Healthcare
ALC
Medical Instruments & Supplies · Healthcare
Medical Instruments & Supplies · Healthcare